Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Sales (2019 - 2025)

Silo Pharma (SILO) has disclosed Return on Sales for 7 consecutive years, with 48.9% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 4710.0% to 48.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 58.63% through Dec 2025, up 229.0% year-over-year, with the annual reading at 58.63% for FY2025, 229.0% up from the prior year.
  • Return on Sales hit 48.9% in Q4 2025 for Silo Pharma, up from 61.61% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.23% in Q2 2022 to a low of 1405.95% in Q4 2021.
  • Historically, Return on Sales has averaged 106.88% across 5 years, with a median of 50.22% in 2024.
  • Biggest five-year swings in Return on Sales: plummeted -139740bps in 2021 and later surged 140594bps in 2022.
  • Year by year, Return on Sales stood at 1405.95% in 2021, then surged by 100bps to 0.01% in 2022, then tumbled by -703270bps to 58.34% in 2023, then plummeted by -65bps to 96.01% in 2024, then skyrocketed by 49bps to 48.9% in 2025.
  • Business Quant data shows Return on Sales for SILO at 48.9% in Q4 2025, 61.61% in Q3 2025, and 66.81% in Q2 2025.